- Home
- RVPH vs OZKAP Comparison
RVPH vs OZKAP Comparison
Compare RVPH & OZKAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- OZKAP
- Stock Information
- Founded
- RVPH 2006
- OZKAP N/A
- Country
- RVPH United States
- OZKAP United States
- Employees
- RVPH N/A
- OZKAP 3096
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- OZKAP Major Banks
- Sector
- RVPH Health Care
- OZKAP Finance
- Exchange
- RVPH Nasdaq
- OZKAP Nasdaq
- Market Cap
- RVPH 32.8M
- OZKAP N/A
- IPO Year
- RVPH N/A
- OZKAP N/A
- Fundamental
- Price
- RVPH $0.43
- OZKAP $16.85
- Analyst Decision
- RVPH Strong Buy
- OZKAP
- Analyst Count
- RVPH 5
- OZKAP 0
- Target Price
- RVPH $9.00
- OZKAP N/A
- AVG Volume (30 Days)
- RVPH 3.5M
- OZKAP N/A
- Earning Date
- RVPH 08-13-2025
- OZKAP N/A
- Dividend Yield
- RVPH N/A
- OZKAP N/A
- EPS Growth
- RVPH N/A
- OZKAP N/A
- EPS
- RVPH N/A
- OZKAP N/A
- Revenue
- RVPH N/A
- OZKAP N/A
- Revenue This Year
- RVPH N/A
- OZKAP N/A
- Revenue Next Year
- RVPH N/A
- OZKAP N/A
- P/E Ratio
- RVPH N/A
- OZKAP N/A
- Revenue Growth
- RVPH N/A
- OZKAP N/A
- 52 Week Low
- RVPH $0.30
- OZKAP N/A
- 52 Week High
- RVPH $4.28
- OZKAP N/A
- Technical
- Relative Strength Index (RSI)
- RVPH 37.84
- OZKAP 58.95
- Support Level
- RVPH $0.38
- OZKAP $16.70
- Resistance Level
- RVPH $0.45
- OZKAP $17.13
- Average True Range (ATR)
- RVPH 0.06
- OZKAP 0.28
- MACD
- RVPH 0.00
- OZKAP 0.06
- Stochastic Oscillator
- RVPH 24.40
- OZKAP 73.03
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About OZKAP Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.